Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R W Emary; Tanya Golubchik; Parvinder K Aley; Cristina V Ariani; Brian Angus; Sagida Bibi; Beth Blane; David Bonsall; Paola Cicconi; Sue Charlton; Elizabeth A Clutterbuck; Andrea M Collins; Tony Cox; Thomas C Darton; Christina Dold; Alexander D Douglas; Christopher J A Duncan; Katie J Ewer; Amy L Flaxman; Saul N Faust; Daniela M Ferreira; Shuo Feng; Adam Finn; Pedro M Folegatti; Michelle Fuskova; Eva Galiza; Anna L Goodman; Catherine M Green; Christopher A Green; Melanie Greenland; Bassam Hallis; Paul T Heath; Jodie Hay; Helen C Hill; Daniel Jenkin; Simon Kerridge; Rajeka Lazarus; Vincenzo Libri; Patrick J Lillie; Catherine Ludden; Natalie G Marchevsky; Angela M Minassian; Alastair C McGregor; Yama F Mujadidi; Daniel J Phillips; Emma Plested; Katrina M Pollock; Hannah Robinson; Andrew Smith; Rinn Song; Matthew D Snape; Rebecca K Sutherland; Emma C Thomson; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Christopher J Williams; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Merryn Voysey; Maheshi N Ramasamy; Andrew J Pollard

The Lancet (2021) - Comments
pubmed: 33798499 doi: 10.1016/s0140-6736(21)00628-0 issn: 0140-6736 issn: 1474-547x

Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, Cristina V Ariani, Brian Angus, Sagida Bibi, Beth Blane, David Bonsall, Paola Cicconi, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins, Tony Cox, Thomas C Darton, Christina Dold, Alexander D Douglas, Christopher J A Duncan, Katie J Ewer, Amy L Flaxman, Saul N Faust